Clinical Trials Logo

Clinical Trial Summary

Regular physical activity is an important public health lever and is recognised as an alternative in the management of certain long-term conditions. To achieve beneficial effects on the body, exercise recommendations are based on several parameters such as duration, intensity and continuous or intermittent nature of the activity. However, the mode of muscle contraction during exercise is generally little considered or poorly defined in these recommendations, which can lead to prescribing errors. In particular, the eccentric contraction modality, which can be found in actions designed to slow down movement (e.g. walking downhill), represents an interesting strategy, but its prescription modalities are still poorly understood. The beneficial effects of physical activity are based in part on the release of molecules (myokines) by the skeletal muscles during exercise, which improve the functioning of the body. However, the effect of downhill walking on the release of myokines by the muscle has been little studied. The lack of knowledge of this effect is therefore an obstacle to the use of this exercise modality to try to optimise physical activity recommendations for health or performance improvement. The aim of this study is therefore to better understand how downhill walking (eccentric muscle contraction) affects the production of molecules by muscles (myokines) during exercise.


Clinical Trial Description

After being informed of the aims, nature and possible risks of the study, written informed consent will be obtained from the subjects. Prior to enrolment, volunteers will undergo a medical evaluation that includes a review of personal and family medical history, any current medications, and a standard physical examination. Compliance with the inclusion/exclusion criteria will be checked during this examination. After enrolment, subjects will perform a treadmill familiarization session. Experimental days: - Subjects will complete a 45-minute walking exercise on a negative gradient treadmill (6 km/h) in a randomised 2-way cross-over design with either a -10% or -20% gradient. - Blood will be sampled immediately pre-exercise, 1-h and 24-h post-exercise for the analysis of muscle myokines. - Exercise-induced muscle fatigue in lower limbs will be evaluated using squat and counter-movement jumps immediately before and post-exercise. - Heart-rate variability will be measured during the eccentric exercise session. - Thigh muscle volume will be measured immediately before and post-exercise. - Exercise-induced myalgia at 24-, 48-, 72- and 96h will be assessed using a visual analogue scale. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06193824
Study type Interventional
Source University Hospital, Clermont-Ferrand
Contact Lise Laclautre
Phone 334.73.754.963
Email promo_interne_drci@chu-clermontferrand.fr
Status Recruiting
Phase N/A
Start date May 4, 2023
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT01369017 - Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Ctr Reference Endotoxin in Normal Volunteers Phase 1
Not yet recruiting NCT02146300 - Effect of the Nasal Provocation on the Breathing Style N/A
Completed NCT02157389 - Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain N/A
Recruiting NCT02298777 - Metabolomic Analysis of Systemic Sclerosis